Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | -1.37% | -10.89% | +18.03% |
14/05 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/05 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.03% | 30Cr | |
+9.58% | 12TCr | |
+12.41% | 11TCr | |
-3.41% | 2.16TCr | |
-12.38% | 2.23TCr | |
-5.29% | 1.92TCr | |
-3.35% | 1.82TCr | |
-38.57% | 1.76TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals : Morgan Stanley Starts Atea Pharmaceuticals at Overweight With $49 Price Target